Promsote, Wanwisa
Xu, Ling
Hataye, Jason http://orcid.org/0000-0003-1986-5752
Fabozzi, Giulia
March, Kylie
Almasri, Cassandra G.
DeMouth, Megan E.
Lovelace, Sarah E.
Talana, Chloe Adrienna http://orcid.org/0000-0002-0313-8502
Doria-Rose, Nicole A. http://orcid.org/0000-0002-5731-3054
McKee, Krisha
Hait, Sabrina Helmold
Casazza, Joseph P. http://orcid.org/0000-0001-5648-4639
Ambrozak, David
Beninga, Jochen
Rao, Ercole
Furtmann, Norbert
Birkenfeld, Joerg
McCarthy, Elizabeth http://orcid.org/0000-0002-9175-5534
Todd, John-Paul
Petrovas, Constantinos http://orcid.org/0000-0002-5067-5810
Connors, Mark http://orcid.org/0000-0002-2108-8705
Hebert, Andrew T.
Beck, Jeremy
Shen, Junqing
Zhang, Bailin
Levit, Mikhail http://orcid.org/0000-0002-4950-3587
Wei, Ronnie R.
Yang, Zhi-yong http://orcid.org/0000-0002-9938-5929
Pegu, Amarendra http://orcid.org/0000-0003-3564-6453
Mascola, John R.
Nabel, Gary J. http://orcid.org/0000-0003-0619-4419
Koup, Richard A.
Article History
Received: 4 August 2022
Accepted: 30 May 2023
First Online: 22 June 2023
Competing interests
: L.X., Z.-Y.Y., G.J.N., R.W., J. Beninga, E.R., J.R.M., R.A.K., N.A.D-R., M.C. and A.P. are inventors on US patents US20200399369A1 and US20200054765A1 granted to Sanofi, The United States of America, as represented by the Secretary, Department of Health and Human Services, and the National Institutes of Health, that discloses the use of trispecific anti-HIV antibodies. L.X., J. Beninga, E.R., N.F., J. Birkenfeld, A.H.H., J. Beninga, J.S., B.Z., M.L., R.W., Z.-Y.Y., G.J.N. are or were employees of Sanofi while engaged in this research project. The other authors declare no competing interests.